IE
IE · IE · IE-PA-EU/1/23/1740/001-002
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
ATC J07BX05
Last synced from HPRA (Ireland) on
Identification
ManufacturerGlaxoSmithKline Biologicals
CountryIE (IE)
ATC codeJ07BX05
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/23/1740/001-002
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Powder and suspension for suspension for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07BX05"
],
"strength": null,
"pa_number": "EU/1/23/1740/001-002",
"substances": [
"Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "06/06/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code J07BX05.
Access this data programmatically
Query Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.